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Backgrounds/Aims: Although laparoscopic cholecystectomy is a common and widely accepted technique, the use of 
prophylactic antibiotics in elective laparoscopic cholecystectomy still remains controversial. The aim of this study is 
to determine whether prophylactic antibiotics could prevent surgical site infection after elective laparoscopic chol-
ecystectomy and to identify any risk factors for surgical site infection. Methods: This study included 471 patients under-
going laparoscopic cholecystectomy between January 2009 and May 2012. Period 1 patients (279) received second 
generation cephalosporin 1 g intravenously after induction of anesthesia, and Period 2 patients (192) were not given 
prophylactic antibiotics. The characteristics and surgical site infections of the patients were compared and analyzed. 
Results: The overall rate of surgical site infection was 1.69% for the total of 471 patients. The incidence of surgical 
site infection was similar for the two Periods: 5 of 279 patients (1.79%) in Period 1, 3 of 192 patients (1.56%) in 
Period 2 (p=0.973). All of the patients with surgical site infections were well treated under conservative treatments 
without any sequelae. The preoperative albumin level (p=0.023) contributed to surgical site infection. Conclusions: 
Prophylactic antibiotics are not necessary for elective laparoscopic cholecystectomy but patients in poor nutritional state 
with low albumin level should consider prophylactic antibiotics. (Korean J Hepatobiliary Pancreat Surg 2015;19:188-193)
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INTRODUCTION
Laparoscopic cholecystectomy (LC) has been the gold 
standard treatment for symptomatic gallstone disease since 
1990.1,2 The main advantages of LC include less post-
operative pain, shorter hospital stays, lower morbidity and 
mortality, and a lower rate of postoperative infection. Out 
of the several advantages over open cholecystectomy, an 
important benefit is the low rate of infective complica-
tions (0.4% to 1.1%), mostly occurring at the umbilical 
port site.3 Because of the low risk of infection, there have 
been many debates on whether prophylactic antibiotics are 
necessary.
Currently, many randomized controlled trials (RCTs) 
have not been able to show any benefit of prophylactic 
antibiotics in low risk LC.4-6 However, the statistical power 
in RCTs has been questioned in some reports, many 
meta-analysis results do not recommend prophylactic anti-
biotics in low risk LC as well.3,7-11 Therefore, more recent 
guidelines on surgical site infection (SSI) from the Scottish 
Intercollegiate Guidelines Network (SIGN) and American 
Society of Health-System Pharmacists (ASHP) do not rec-
ommend prophylactic antibiotics in low risk elective 
LC.12,13 But prophylactic antibiotics are still recommended 
for the high-risk group.
On the other hand, Matsui et al.14 have claimed that 
underreporting of SSIs may have occurred in previous tri-
als and prophylactic antibiotics should be recommended 
for LC to reduce SSIs. Recent updates by Centers for 
Disease Control (CDC) have reported SSIs are now the 
most common healthcare-associated infection (HAI), ac-
counting for 31% of all HAIs among hospitalized 
patients.15 With increased awareness of SSIs, criteria for 
SSI by CDC have been updated to minimize subjective 
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evaluation of the wound and more detailed classifications 
are now in place.15 With a new guideline by CDC on the 
way, the role of prophylactic antibiotics should be care-
fully analyzed with well-gathered data.
The aim of this study was to determine whether pro-
phylactic antibiotics could prevent surgical site infection 
after elective LC and to identify the high-risk group for 
SSI.
MATERIALS AND METHODS
We retrospectively reviewed medical records of 534 
consecutive patients who received elective laparoscopic 
cholecystectomy at Severance Hospital of the Yonsei 
University Health System in Seoul, Korea between 
January 2009 and May 2012 by a single surgeon. Those 
patients diagnosed with gallbladder empyema or acute 
cholecystitis were excluded from the study, in total, 63 
patients. Diagnoses of patients included gallstones, chron-
ic cholecystitis, gallbladder polyp, and adenomyomatosis. 
Thus, a total of 471 patients were evaluated and they were 
divided into two periods. Period 1 was from January 2009 
to March 2011. During this period, patients received a 
routine administration of 1 g of second-generation cepha-
losporin intravenously after the induction of anesthesia. 
Prophylactic antibiotic was given only once for each 
operation. During period 2, from April 2011 to May 2012, 
patients did not receive any prophylactic antibiotics. There 
were 279 patients in period 1 and 192 patients in period 
2. Data were analyzed between the periods.
Demographic data were collected for all patients, includ-
ing age, gender, body mass index (BMI), American Society 
of Anesthesiologists score (ASA score), information on dia-
betes status, length of hospital stay, operative time, and 
gallbladder perforation during the operation. The length of 
hospital stay was defined as the number of days in the 
hospital from admission to discharge. Clinical character-
istics and perioperative results were compared between the 
two periods.
Preoperative laboratory results were gathered for all pa-
tients within 1 month from the operation. The gathered 
information included white blood cell count (WBC), he-
moglobin, creatinine, cholesterol, albumin, aspartate ami-
notransferase (AST), alanine aminotransferase (ALT), and 
bilirubin.
All patients underwent operation by a single surgeon. 
LC was performed using 3-port placements in all cases. 
A transverse supraumbilical incision was made and a 12 
mm camera port was introduced using a Veress needle. 
Two additional 5 mm working ports were placed under 
direct vision in the right subcostal and subxiphoid areas.
Examination for SSI was made until hospital discharge 
and again at the first postoperative visit. All patients were 
followed up within 7 days from the discharge in the out-
patient department and again in 2 months. Postoperative 
SSIs were defined according to the CDC guidelines.16 
Superficial incisional SSI was defined to be an infection 
involving only skin and subcutaneous tissue of an incision 
within 30 days of the operation. Additionally, the patient 
needs to have at least one of the following: purulent dis-
charge from the superficial incision, positive culture result, 
incision that is deliberately opened by an attending physi-
cian with positive culture result, or in cases of cultures 
not taken, showing signs of inflammation. Diagnosis of 
superficial incision SSI by the attending physician is also 
included in the definition.15 Deep incisional SSI was de-
fined to be an infection involving deep soft tissues of the 
incision; and organ/space SSI was defined to be an in-
fection involving any part of body deeper than the fas-
cial/muscle layers, that is manipulated during the operation.15 
According to the definition of the CDC guidelines, a stitch 
abscess alone with minimal inflammation and discharge 
confined to the points of suture penetration was not con-
sidered a SSI. In a case of SSI, the standard management 
of wound care was provided: including antibiotics, dress-
ing, or intervention drainage.
Statistical analysis
Analysis was performed with the Statistical Package for 
Social Sciences version 20 (SPSS, Chicago, IL, USA). A 
Shapiro-Wilk test was used to test normality for each 
quantitative variable. Comparisons between the groups 
were performed using the Fisher’s exact test, or chi-square, 
as appropriate.
Binary logistic regression was performed to assess risk 
factors for SSI. The following independent variables were 
used: antibiotic use, age, sex, BMI, ASA score, WBC, he-
moglobin, albumin, AST, ALT, bilirubin, and history of 
diabetes. SSI was used as the dependent variable. The lev-
el of statistical significance was set to be 0.05.
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Table 1. Clinical characteristics (N=471)
Period 1 Period 2 p-value
Age (years)
Gender (Male:Female)
BMI (kg/m2)
ASA score, n (%)
  1
  2
  3
60.1±10.8 (19-86)
  119:160 (42.4%:57.6%)
  24.2 (18.1-32.1)
 
198 (70.9)
75 (27.0)
6 (2.2)
58.6±12.3 (32-85)
   83:109 (43.2%:56.8%)
  23.9 (16.4-32.9)
 
130 (67.7)
55 (28.6)
7 (3.6)
0.758
0.866
0.144
0.553
 
 
 
BMI, body mass index; ASA score, American Society of Anesthesiologists score
Table 2. Preoperative Laboratory evaluations
Period 1 Period 2 p-value
WBC (/l)
Hemoglobin (g/dl)
Creatinine (mg/dl)
Cholesterol (mg/dl)
Albumin (g/dl)
AST (IU/L)
ALT (IU/L)
Bilirubin (mg/dl)
6,498.0±2,629.7
13.5±1.7 (6.9-17.3)
 1.1±0.3 (0.47-4.20)
181.0±38.2 (27-337)
4.4±0.4 (2.0-5.4)
24.5±47.7 (10-783)
23.6±24.4 (4-244)
0.7±0.5 (0.9-5.6)
6,517.6±1,832.3
13.9±1.6 (7.9-17.8)
 0.8±0.3 (0.45-3.15)
180.9±35.3 (79.0-271.0)
4.4±0.3 (3.5-5.0)
22.7±10.6 (10-83)
26.1±27.6 (6-223)
0.7±0.5 (0.2-4.3)
0.550
0.973
0.364
0.962
0.891
0.235
0.298
0.550
WBC, white blood cell count; AST, aspartate aminotransferase; ALT, alanine aminotransferase
RESULTS
Demographic characteristics
The mean ages of the patients were 60.1±10.8 years for 
period 1 and 58.6±12.3 years for period 2 (p=0.758). The 
gender ratio between the two periods showed similar char-
acteristics with male to female ratios of 42.4%: 57.6% in 
period 1 and 43.2%: 56.8% in period 2. The median body 
mass indices were 24.2 kg/m2 (range, 18.1-32.1 kg/m2) for 
period 1 and 23.9 kg/m2 (range, 16.4-32.9 kg/m2) for peri-
od 2 (p=0.866). Most patients in the study were of normal 
weight, in terms of the body mass index. To assess the 
severity of underlying conditions, the ASA score was 
used. In period 1, 198 patients (70.9%) had a score of 
1 and in period 2, 130 patients (67.7%) had a score of 
1. Most patients were in the normal healthy patient 
category. Only 2.2% in period 1 and 3.6% in period 2 
had an ASA score of 3 and no patients had a higher ASA 
score. A comparison of the baseline characteristics be-
tween the two periods showed no significant differences 
regarding age, sex, body mass index, and ASA score. The 
clinical characteristics between the two periods are sum-
marized in Table 1.
Preoperative laboratory evaluation
WBC was used to evaluate the presence of an in-
flammatory condition prior to operation. The results 
showed a mean WBC of 6498.0±2629.7/ul in period 1, 
and 6517.6±1832.3/ul in period 2 (p=0.550). No obvious 
inflammation was present in both groups prior to 
operation. The mean values of preoperative laboratory re-
sults showed that patients were in normal healthy con-
dition without anemia and renal insufficiency. The mean 
values for albumin and cholesterol also suggested that the 
patients in both group were in a good nutritional state. 
The results of AST and ALT values showed normal liver 
functions prior to operation and mean bilirubin level in 
both periods were within normal range. Preoperative labo-
ratory results were compared between the periods and the 
results also showed no significant difference (Table 2).
Postoperative results
The mean length of hospital stay during period 1 was 
2.7±1.9 days and 2.9±1.5 days for period 2 (p=0.882). 
The total operation time during the two periods was sim-
ilar with 51.0±52.9 minutes for period 1 and 50.3±40.9 
minutes for period 2 (p=0.154). Intraoperative gallbladder 
perforation also occurred at a similar rate in both periods 
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Table 4. Summary of binary logistic regression analysis for 
risk factor of surgical site infection
p-value Odds ratio 95% CI
Antibiotics use
Age
Sex
BMI
ASA score
WBC
Hemoglobin
Albumin
AST
ALT
Bilirubin
Diabetes
0.913
0.224
0.996
0.708
0.815
0.507
0.073
0.023
0.967
0.577
0.270
0.515
0.920
1.036
0.996
0.956
0.836
1.000
0.696
0.215
0.999
0.982
0.107
2.038
0.203-4.159
0.978-1.096
0.220-4.505
0.754-1.212
0.185-3.771
0.966-1.018
0.467-1.035
0.058-0.806
0.976-1.023
0.922-1.046
0.003-3.443
0.239-17.396
BMI, body mass index; ASA score, American society of an-
esthesiologists score; WBC, white blood cell count; AST, as-
partate aminotransferase; ALT, alanine aminotransferase; 
95% CI, 95% confidence interval
Table 3. Postoperative results
Period 1 Period 2 p-value
Hospital stay (days)
Operation time (min.)
Intraoperative 
gallbladder perforation
Surgical site infection
  Yes
  No
2.7±1.9
51.0±52.8
 22 (11.5%)
 
 
  5 (1.79%)
274 (98.2%)
2.9±1.5
50.3±40.9
 29 (10.4%)
 
 
  3 (1.56%)
189 (98.4%)
0.882
0.154
0.764
 
0.973
 
 
(11.5% in period 1 and 10.4% in period 2, p=0.764) 
Postoperative results did not show significant results be-
tween the two periods, including mean length of hospital 
stay, operation time and intraoperative gallbladder perfo-
ration (Table 3).
Incidences of surgical site infection
The incidences of SSIs are shown in Table 3. Five 
(1.79%) patients developed SSIs during period 1 and three 
(1.56%) in period 2. There was no statistically significant 
difference in the development of SSI between the periods 
(p=0.973). SSIs presented during both periods were super-
ficial incisional. All patients, who developed SSIs, were 
well treated with conservative treatments without any 
sequelae.
Risk factors in development of surgical site 
infection
In a further search for risk factors associated with the 
development of surgical site infection, binary logistic re-
gression analysis was also carried out. With surgical site 
infection as a dependent variable, only the albumin level 
showed a significant impact on surgical site infection 
(p=0.023). Nutritional state may play an important role in 
SSI. Antibiotic use was shown not to have a significant 
influence on SSI (p=0.913). The results are summarized 
in Table 4.
DISCUSSION
Since the introduction of LC, role of prophylactic anti-
biotics have been questioned because of low infection 
rates. Most of the recent randomized trials and their 
meta-analysis have concluded that low risk elective LC 
does not require prophylactic antibiotics.3-11 Our study re-
sults concur with these previous trials, thus no benefit of 
prophylactic antibiotics was found. Despite much evi-
dence on the unnecessity of prophylactic antibiotics in 
LC, a more recent RCT by Matsui et al.14 has recom-
mended three doses of perioperative antibiotics to reduce 
SSI in elective low-risk LC. That study emphasized a pos-
sibility of overlooked SSIs and inadequate statistical pow-
er as the reasons for its discrepancy with previous trials.14 
The underreporting of SSIs during follow-up should be 
carefully addressed in order to obtain a reliable data. Our 
data was collected from a single surgeon experience and 
the reporting of SSI properly followed the CDC guidelines 
to minimize underreporting. SSIs are defined to be in-
fections occurring within 30 days of an operation for LC. 
However, in this study the follow-up of the patients was 
not done at 30 days from the surgery. The follow-up was 
scheduled in the outpatient department at postoperative 7 
days and 2 months. In a case of complicated SSI, the pa-
tient would return to the outpatient department prior to 
the scheduled appointment and will be accounted for in 
the analysis. However, in a minor SSI, the case may have 
been underreported. This limitation may have influenced 
the incidences of SSI. To minimize the underreporting of 
the SSIs for future studies, it is essential to have a more 
systemic and specific web-based data collection system. 
Despite the controversy, current guidelines by SIGN 
and ASHP do not recommend use of prophylactic anti-
biotics in low risk LC, as based on the evidence from 
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many RCTs. Nevertheless, prophylactic antibiotics are 
recommended for the high-risk group. In defining the 
high-risk group, both guidelines acknowledge bile spillage 
(intraoperative gallbladder rupture), conversion to lapa-
rotomy, acute cholecystitis, jaundice, pregnancy, im-
munosuppression, and insertion of a prosthetic device.12,13 
But, intraoperative cholangiogram is considered to be a 
high-risk only in the SIGN guideline. In the therapeutic 
guideline by ASHP, the high-risk factors for SSI are con-
sidered to be: emergency procedures, diabetes, long proce-
dure duration, age ＞70 years, ASA score of 3 or higher, 
and an episode of colic within 30 days before the procedure. 
These discrepancies in the definition of a high-risk group 
should be addressed in future studies. Furthermore, our 
data have also shown nutritional state, in terms of albumin 
level, as a risk factor for SSI. The preoperative albumin 
level was similar between the groups, but patients with 
a higher preoperative albumin level were at a lower risk 
of SSIs.
Although our data could not confirm the high-risk vari-
ables from these guidelines, it is noteworthy to consider 
nutritional state as a possible risk factor in SSI for LC; 
thus further evaluation is warranted.
The main limitation of this study includes the lack of 
statistical power to overcome the type II error. With the 
incidences of reported SSIs at less than 2%, to have a sig-
nificance power of 80% and lower limit of a 2-sided 95% 
confidence interval, more than 4,000 patients are necessary. 
Our study was based on a single surgeon experience with 
the intention of properly assessing SSIs to reduce under-
reporting and compensate for this limitation. Nevertheless, 
results of low SSI rates in both groups suggest that further 
study with a sufficiently powered sample size may have 
a limited value.
When the Center for Disease Control (CDC) first in-
troduced its guideline on SSI in 1999, SSI was reported 
to be third most common nosocomial infection, account-
ing for 14 to 16%.16 Since then, many advances have been 
made in infection control practices. However, the most 
current definition of SSI by CDC states that SSI is now 
the most common HAIs, which accounts for 31%.15 
Surveillance of SSI has been emphasized in the reduction 
of SSI risk. With the new CDC guideline on SSI expected 
soon, definition and surveillance protocol for SSI are be-
ing updated. With recent modifications in surveillance of 
SSI and more awareness, a more refined classification is 
recommended in the effort to reduce SSIs.
In conclusion, we could not find a benefit of prophy-
lactic antibiotics on surgical site infection in laparoscopic 
cholecystectomy. SSIs were not associated with an in-
crease in length of hospital stay and patients were well 
treated with conservative care in the outpatient department. 
Prophylactic antibiotics are not necessary for elective LC, 
but patients in poor nutritional state with low albumin lev-
el should consider prophylactic antibiotics.
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